Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Infection|July 28, 2020
HIV transmission by human bite: a case report and review of the literature-implications for post-exposure prophylaxisDirk Schürmann, Christian Hoffmann, Miriam S Stegemann, et al.
BMJ Open Respiratory Research|January 21, 2020
Indwelling pleural catheters for non-malignant pleural effusions: report on a single centre's 10 years of experienceNikolaj Frost, Christoph Ruwwe-Glösenkamp, Matthias Raspe, et al.
Clinical and Translational Allergy|August 25, 2021
Role of IL-17 in atopy-A systematic reviewMaja A Hofmann, Joachim W Fluhr, Christoph Ruwwe-Glösenkamp, et al.
Respiration; International Review of Thoracic Diseases|December 5, 2021
Impact of Ventilation Modes on Bronchoscopic Chartis Assessment Outcome in Candidates for Endobronchial Valve TreatmentJacopo Saccomanno, Christoph Ruwwe-Glösenkamp, Konrad Neumann, et al.
BMC Pulmonary Medicine|December 4, 2019
Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centre's ten years of experienceNikolaj Frost, Martin Brünger, Christoph Ruwwe-Glösenkamp, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 2, 2020
An Integrative Approach of the Fissure Completeness Score and Chartis Assessment in Endobronchial Valve Treatment for EmphysemaKarin Klooster, T David Koster, Christoph Ruwwe-Glösenkamp, et al.
Clinical Lung Cancer|July 5, 2020
Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs AnalysisNikolaj Frost, Tamar Zhamurashvili, Maximilian von Laffert, et al.
ERJ Open Research|February 3, 2021
Endoscopic lung volume reduction with endobronchial valves in very low D LCO patients: results from the German Registry - Lungenemphysemregister e.VPavlina Lenga, Christoph Ruwwe-Glösenkamp, Christian Grah, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 patientsNikolaj Frost, Antje Tessmer, Alexander Schmittel, et al.
Journal of Global Antimicrobial Resistance|December 26, 2022
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trialFlorian Kurth, Elisa T Helbig, Lena J Lippert, et al.
Pageof 2